Clofoctol is primarily used as an antibacterial agent, particularly in the treatment of respiratory tract infections. It is effective against a range of Gram-positive bacteria and is often utilized in oral formulations for conditions such as bronchitis and tonsillitis. Its mechanism involves inhibiting bacterial protein synthesis, which helps reduce bacterial load in respiratory secretions. Due to its favorable tissue penetration, clofoctol accumulates in lung tissue and bronchial secretions, enhancing its therapeutic effect in lower respiratory infections. It is considered especially useful in mild to moderate infections where outpatient treatment is appropriate.